its application in the third quarter. While the drug increases good cholesterol and lowers bad cholesterol -- something GlaxoSmithKline's (NYSE: GSK The company hasn't even started the study and expects that it won't be substantially enrolled until the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to A Takeout Target Swims Along
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account